1.39

0.72% 0.01

Bone Biologics Corp (BBLG)

Overview News Price History Financials Why BBLG Down? Discussions Forecast Stock Split

Bone Biologics Corp stock is traded at $1.39, with a volume of 24,000. It is up +0.72% in the last 24 hours and up +12.10% over the past month. Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Previous Close:

$1.38

Open:

$1.32

24h Volume:

24,000

Relative Volume:

0.45

Market Cap:

$2.50M

Revenue:

Net Income/Loss:

$-2.86M

P/E Ratio:

-0.5544

EPS:

-2.5071

Net Cash Flow:

$-2.57M

1W Performance:

-2.11%

1M Performance:

+12.10%

6M Performance:

-14.20%

1Y Performance:

-53.97%

1-Day Range:

$1.32

$1.39

1-Week Range:

$1.25

$1.5299

52-Week Range:

$1.05

$4.1299

Bone Biologics Corp Stock (BBLG) Company Profile

Name

Bone Biologics Corp

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

(781) 552-4452

Address

2 BURLINGTON WOODS DRIVE,, BURLINGTON

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

BBLG's Discussions on Twitter

Compare BBLG vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BBLG Bone Biologics Corp	1.39	2.50M	0	-2.86M	-2.57M	-2.5071
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Bone Biologics Corp Stock (BBLG) Latest News

Jul 10, 2026

Orthobiologics Devices And Equipment Market Report 2026 Market Outlook Supported By A Forecast 8% CAGR - openPR.com

Jul 10, 2026

Jul 09, 2026

Bone Biologics Announces $9 Million Private Placement for Spine Fusion Innovation and Clinical Trials Funding 12 - Minichart

Jul 09, 2026

Bone Biologics Raises $2.7 Million in Private Placement; Adds $6 Million Upside From Warrants - TradingView

Jul 09, 2026

Bone Biologics (BBLG) raises $3M in private placement with up to $6M via warrants - Stock Titan

Jul 09, 2026

Jul 08, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Jul 08, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jul 08, 2026

Why iOThree Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 08, 2026

What Put Bone Biologics (NASDAQ:BBLG) on Nasdaq Composite Radar? - Kalkine Media

Jul 08, 2026

Orthobiologics Market Size to Surge USD 12.55 Billion by 2035 - Precedence Research

Jul 08, 2026

Jul 07, 2026

Bone Biologics raises $3M now, with up to $6M more from warrants - Stock Titan

Jul 07, 2026

Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance

Jul 07, 2026

Jul 06, 2026

Demineralized Bone Matrix Market Report 2026 Market Outlook Supported By A Forecast 6.3% CAGR - openPR.com

Jul 06, 2026

Jul 03, 2026

AMAT Q2 2026 Earnings: EPS Surpasses Estimates But Stock Declines Over 7%Full Year Guidance - dars.gov.et

Jul 03, 2026

Jul 02, 2026

Executive pay and board elections at Bone Biologics (NASDAQ: BBLG) - Stock Titan

Jul 02, 2026

Jun 30, 2026

CISS Q3 2025 Earnings: Net Loss of $0.58 Per Share; Stock Trades at $0.61Full Year Guidance - dars.gov.et

Jun 30, 2026

ADRMD Stock Price and Chart — OTC:ADRMD - TradingView

Jun 30, 2026

Jun 25, 2026